Service delivery workbench
SCRIMED turns packaged offers into scoped work orders buyers can fund, review, and accept.
This workbench converts product and service packages into delivery phases, work-order templates, acceptance criteria, artifacts, buyer handoffs, margin protections, and retained healthcare approval gates.
Delivery rule
Every service starts with scope, acceptance criteria, proof route, and retained boundary.
SCRIMED Service Delivery Workbench converts packaged offers into scoped work orders, delivery phases, acceptance criteria, buyer handoffs, proof routes, margin protections, and retained healthcare authority gates. It is a product and services execution control surface only. It is not a statement of work, contract approval, legal advice, accounting advice, tax advice, audited financial reporting, contractual SLA, uptime guarantee, managed-service commitment, customer permission, revenue guarantee, profit-margin guarantee, clinical validation, compliance certification, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.
Delivery offers
Each offer now has kickoff inputs, deliverables, acceptance criteria, margin rules, and stops.
Workflow Intelligence Assessment Delivery
Turn one to three operational pain points into a no-PHI workflow map, automation scorecard, evidence inventory, and next-package decision.
- Window: 2 to 4 weeks
- Inputs: Named sponsor and workflow owner, Target workflow list, Current-state questions and pain points, No-PHI discovery boundary acknowledgement
- Acceptance: All scoped workflows have owner, friction, evidence, and next action recorded, Buyer confirms no PHI or production credentials were provided, Recommendation is tied to a proof route and retained boundary
- Margin: Fixed fee, Capped workflow count, Change order for expanded mapping
- Operational intelligence only; no clinical advice, production automation, PHI processing, or guaranteed savings.
Health Records Safety Assessment Delivery
Map safe record extraction, source attribution, patient-safety linting, interoperability standards, and live-data approval gates without accepting PHI.
- Window: 2 to 5 weeks
- Inputs: Source system class, Document or record-type inventory, Privacy/security owner, Clinical reviewer owner for safety questions
- Acceptance: Every source type has a safety check and retained approval gate, Synthetic extraction path is separated from live-data path, Blocked actions are visible in the handoff
- Margin: Assessment excludes live connector build, Separate protected-pilot or connector SOW, Reusable extraction checklist
- No-PHI extraction planning only; patient matching, production connectors, writeback, payer submission, and clinical action remain blocked.
Interoperability Readiness Sprint Delivery
Prepare a standards-aware connector path, synthetic conformance evidence, and implementation sequence before production access is requested.
- Window: 30 to 45 days
- Inputs: Target integration pattern, Standards named by buyer, Integration owner, Security and privacy review path
- Acceptance: Every target standard has evidence route, owner, and gate, No live endpoint dependency exists inside sprint scope, Production connector approval is separated from readiness work
- Margin: Conformance templates reused, No custom live connector in sprint, Connector SOW priced separately
- Readiness and synthetic conformance only; production connector, PHI, security, privacy, and customer environment approval remain external gates.
TrustOS AI Governance Audit Delivery
Create a governed AI adoption review with claims controls, oversight map, audit evidence plan, and approval-gate ladder.
- Window: 2 to 4 weeks
- Inputs: Intended-use language, AI workflow or vendor context, Governance sponsor, Qualified reviewer owner
- Acceptance: Claims are classified as approved, evidence-required, or prohibited, Human review ownership is explicit, Legal, security, clinical, and regulatory conclusions are routed to qualified reviewers
- Margin: Repeatable TrustOS review pack, External review excluded unless scoped, Retainer path for continuous review
- Governance readiness only; legal, regulatory, security, certification, and clinical authority require qualified external review.
Synthetic Pilot Evaluation Delivery
Run governed synthetic workflow evaluation with workflow packets, Trust Cards, QA evidence, metrics, and protected-pilot recommendation.
- Window: 45 to 90 days
- Inputs: Sponsor and review team, Synthetic packet approval, Workflow count and success metrics, Protected evidence and release owners
- Acceptance: Synthetic scenarios are approved before execution, QA evidence and claim guard are complete before buyer proof language, Protected evidence release remains AAL2 gated
- Margin: Paid pilot, Capped workflow count, Evidence-room and custom diligence priced separately
- Synthetic evaluation only; no diagnosis, treatment, payer submission, patient outreach, live PHI, or production connector execution.
Enterprise Proof and Deal Room Delivery
Package buyer-specific diligence, proof packets, release decisions, protected evidence-room boundaries, quote-to-contract inputs, and next action.
- Window: 2 to 8 weeks depending on buyer diligence
- Inputs: Buying committee, Diligence request list, Release decision owner, Protected workspace access path
- Acceptance: Every external packet has release authority, recipient control, and access-log route, Custom claims are routed to Claim Guard, Contract and pricing commitments are separated from proof work
- Margin: Paid diligence line item, Expiration date on custom packet labor, Legal/security review scoped separately
- Diligence activation only; external sharing, customer permission, certification, signed contracts, and production activation remain gated.
Continuous Review and Innovation Retainer Delivery
Operate agent-assisted accuracy review, evidence attribution, claims drift, security drift, incident learning, and internal innovation backlog with human approval gates.
- Window: Monthly retained cadence
- Inputs: Accountable owner, Review loop selection, Escalation rule, Innovation research disclosure boundary
- Acceptance: Human owner approves every remediation or public claim, Quantum or future research stays internal unless approved, Escalations become separately scoped work when implementation labor is required
- Margin: Recurring retainer, Escalation labor priced separately, Research backlog separated from production commitments
- Agent-assisted and internal-research cadence only; humans approve remediation, public claims, production changes, and innovation disclosures.
Delivery phases
Delivery is repeatable from qualification through handoff without drifting into unsupported commitments.
Qualify
Confirm buyer, sponsor, package, budget posture, no-PHI boundary, and decision owner before work is promised.
- Owner: Revenue Operations
- Exit: Sponsor named, Scope lane selected, Boundary accepted
- Hard stop: Stop when sponsor, package, or no-PHI boundary is missing.
Scope
Translate buyer interest into capped workflow count, deliverables, acceptance criteria, proof routes, and excluded work.
- Owner: Product Console and Delivery Lead
- Exit: Scope matrix approved, Acceptance criteria recorded, Excluded claims listed
- Hard stop: Stop when requested work requires contract, legal, finance, PHI, connector, or clinical authority approval.
Kickoff
Set owner map, cadence, artifacts, review checkpoints, communication path, and escalation rules.
- Owner: Delivery Lead and Customer Operations
- Exit: Kickoff brief, Work-order board, Human-review owners
- Hard stop: Stop when buyer requests autonomous communication, calendar send, or unsupported SLA commitments.
Configure
Prepare synthetic fixtures, task plans, evidence routes, TrustOS gates, and QA checks for scoped work orders.
- Owner: Platform, AgentOS, Atlas, TrustOS, and QA
- Exit: Fixture plan, Agent task map, QA checklist, Blocked action list
- Hard stop: Stop when live endpoints, production credentials, PHI, or patient identifiers are requested.
Execute
Run scoped no-PHI work orders, collect evidence, route issues, and prevent claim expansion.
- Owner: Delivery Lead, AgentOS, TrustOS, and named human reviewers
- Exit: Evidence packet, Issue queue, Acceptance memo candidate
- Hard stop: Stop when a result would imply diagnosis, treatment, reimbursement, certification, security approval, or production authorization.
Review
Approve or block buyer-facing language, external packet release, business terms, security claims, and clinical implications.
- Owner: Claim Guard, Legal Ops, Security, Finance, and Clinical Governance as needed
- Exit: Release decision, Blocked claims, Qualified-review notes
- Hard stop: Stop when qualified review is missing for legal, security, finance, tax, clinical, regulatory, or certification language.
Handoff
Deliver artifacts, confirm acceptance, route unresolved gates, and recommend next paid package or retainer.
- Owner: Delivery Lead, Revenue Operations, and Customer Operations
- Exit: Buyer handoff packet, Expansion recommendation, Retained boundary register
- Hard stop: Stop when buyer asks for implementation expansion without change order, SOW, protected pilot, or license approval.
Work orders
Work orders make service execution concrete enough to assign, audit, and accept.
Buyer Discovery and No-PHI Intake
Capture buyer problem, sponsor, owner, offer, and desired decision Reject PHI, patient identifiers, production credentials, and live endpoints Map requested claims to approved, evidence-required, or prohibited language
- Owner: Revenue Operations
- Acceptance: Sponsor and owner are recorded, No-PHI boundary is acknowledged, Offer and package are selected
- Hard stops: PHI in intake, No sponsor, Unsupported claim requested
- Proof: /client-onboarding, /offerings, /claims
Scope Matrix and Acceptance Plan
Convert offer into capped workflow count, deliverables, review owners, and evidence routes Define acceptance criteria and excluded work Attach margin protections and escalation triggers
- Owner: Product Console
- Acceptance: Deliverables and acceptance criteria are paired, Excluded work is explicit, Escalation triggers are mapped
- Hard stops: Uncapped scope, No acceptance criteria, Contract-like commitment without review
- Proof: /service-delivery, /enterprise-business-ops, /operational-efficiency
Workflow and System Boundary Map
Map current-state workflow, source systems, handoffs, and blocked actions Separate synthetic, protected, and production paths Identify standards or record-safety dependencies
- Owner: Delivery Lead and Interoperability
- Acceptance: Every handoff has owner and evidence route, Every live-data dependency has retained approval gate, Every blocked action has workaround
- Hard stops: Live endpoint dependency, No owner for clinical or data gate, No workaround for blocked action
- Proof: /interoperability, /health-records, /limitations-workarounds
Synthetic Fixture and Evidence Plan
Select synthetic scenarios and expected outputs Map evidence references and TrustOS checkpoints Define QA pass/fail and retained packet requirements
- Owner: AgentOS, Atlas, and QA
- Acceptance: Synthetic scenarios are no-PHI, Expected outputs have evidence references, QA and claim guard are attached before buyer proof
- Hard stops: PHI scenario, No evidence reference, No QA checkpoint
- Proof: /evaluation, /qa-evidence, /qa-completion-bridge
Standards and Record Safety Crosswalk
Map record types and standards Attach source-attribution and patient-safety lint checks Route live-data, connector, and writeback gates
- Owner: Interoperability, Health Records Safety, and Clinical Governance
- Acceptance: Standards are named, Source attribution is planned, Writeback, payer submission, and live clinical actions are blocked
- Hard stops: Patient matching requested, EHR writeback requested, Payer submission requested
- Proof: /health-records, /interoperability, /clinical-authority-readiness
TrustOS Claim and Authority Review
Classify claims and authority language Route legal, security, certification, clinical, and regulatory claims to qualified review Block unsupported buyer-facing proof statements
- Owner: TrustOS, Claim Guard, Legal Ops, Security, and Clinical Governance
- Acceptance: Every public or buyer-facing claim has status, Qualified-review needs are explicit, Blocked claims are present in handoff
- Hard stops: Legal advice requested, Certification claim requested, Clinical authority claim requested
- Proof: /qa-claim-guard, /approvals-readiness, /global-certification-readiness
Buyer Proof Packet and Release Control
Assemble evidence inventory and buyer-facing summary Attach release decision, reviewer signoff, recipient rules, and access-log path Prevent customer-specific external sharing until AAL2 release chain is complete
- Owner: Buyer Diligence and Release Steward
- Acceptance: Release decision exists, Recipient control exists, Access-log route exists, Claim guard is complete
- Hard stops: No release decision, No recipient control, No AAL2 protected route
- Proof: /qa-buyer-proof-release, /buyer-release-control-run, /pilot-workspace/access
Delivery Retro and Expansion Recommendation
Compare acceptance criteria to delivered artifacts Record unresolved gates, risks, margin lessons, and buyer next action Recommend next package, protected pilot, retainer, or stop
- Owner: Delivery Lead and Growth Engine
- Acceptance: Acceptance result is recorded, Unresolved gates remain visible, Expansion recommendation does not create a contract or revenue guarantee
- Hard stops: Implementation expansion without SOW, Revenue guarantee requested, Unreviewed public claim
- Proof: /growth-engine, /offerings, /service-delivery
Activation gates
Service delivery fails closed before PHI, clinical action, contracts, unsupported SLAs, or production connectors.
No-PHI Intake Gate
Every discovery, upload, intake, or buyer workshop.
- Owner: Revenue Operations and Privacy
- Fail closed: Reject input, remove sensitive content from scope, and route to protected/privacy review.
- Does not authorize PHI processing or production data access.
Sponsor and Owner Gate
Before scoping, kickoff, or delivery scheduling.
- Owner: Revenue Operations
- Fail closed: Keep request in nurture/onboarding until ownership exists.
- Does not imply procurement approval or customer permission.
Scope and Acceptance Gate
Before a work order starts.
- Owner: Product Console and Delivery Lead
- Fail closed: Block delivery and return to scope matrix.
- Does not create a contract, SOW, or implementation authorization.
Legal Finance Contract Gate
Pricing, SOW, payment, revenue-recognition, tax, contract, investor, or board language appears.
- Owner: Legal Ops, Finance, Accounting, Tax, and qualified reviewers
- Fail closed: Use readiness-only language and remove contract-like commitments.
- Does not provide legal, accounting, tax, investment, securities, valuation, or audited financial advice.
Claim Guard and Authority Gate
External claim, buyer proof, investor packet, clinical implication, security statement, or certification language.
- Owner: Claim Guard, TrustOS, Legal Ops, Security, and Clinical Governance
- Fail closed: Block language and route to qualified review.
- Does not certify security/compliance or grant clinical, regulatory, reimbursement, or live-care authority.
Protected Buyer Evidence Release Gate
Buyer-specific packet, protected proof, customer-specific evidence, or external sharing request.
- Owner: Release Steward and Buyer Diligence
- Fail closed: Share public-safe summary only or keep evidence internal.
- Does not grant customer permission, external distribution approval, or protected evidence access.
Connector and Live Data Gate
Production connector, live endpoint, EHR writeback, payer submission, patient matching, or data exchange request.
- Owner: Platform, Interoperability, Privacy, Security, and Customer Environment Owners
- Fail closed: Use synthetic fixtures, standards mapping, and readiness-only workaround.
- Does not authorize PHI, production connectors, writeback, payer submission, or patient matching.
Clinical Action Gate
Diagnosis, treatment, patient outreach, triage, prescribing, clinician substitution, or live-care language.
- Owner: Clinical Governance and qualified clinical/legal reviewers
- Fail closed: Block clinical action and convert to synthetic planning or governance review.
- Does not authorize live clinical care or autonomous medical decision-making.
Artifacts
Every service leaves behind reviewable evidence, not informal process memory.
Scoped Intake Sheet
Capture buyer, sponsor, target offer, workflow questions, and no-PHI boundary.
- Fields: Sponsor, Workflow target, Offer, No-PHI acknowledgement, Decision owner
- Release: Internal and buyer-facing after no-PHI check.
- Does not create contract, SOW, or production authorization.
Scope Matrix
Tie deliverables to acceptance criteria, proof routes, excluded work, margin protections, and escalation triggers.
- Fields: Deliverables, Acceptance criteria, Excluded work, Proof routes, Margin controls
- Release: Buyer-facing only after delivery lead and business owner review.
- Does not approve price, legal terms, accounting, tax, or revenue recognition.
Work Order Board
Track tasks, owners, status, evidence links, hard stops, and human-review checkpoints.
- Fields: Task, Owner, Status, Evidence, Hard stop, Review owner
- Release: Internal by default; buyer snapshot allowed when sensitive content is absent.
- Does not contain PHI, secrets, production credentials, or customer confidential artifacts.
Evidence Packet
Package synthetic fixtures, outputs, source attribution, TrustOS decisions, QA checks, and blocked actions.
- Fields: Scenario, Output, Evidence reference, TrustOS decision, QA status, Blocked action
- Release: Protected route or public-safe summary depending on buyer release decision.
- Does not authorize customer-specific release, clinical validation, security certification, or live workflow use.
Claim and Authority Memo
Classify sales, buyer, investor, legal, financial, clinical, security, and regulatory language before external use.
- Fields: Claim, Status, Evidence, Reviewer, Blocked language, External review need
- Release: External use requires authorized claim status or qualified-review completion.
- Does not replace legal, accounting, tax, security, clinical, regulatory, or certification review.
Acceptance and Handoff Memo
Close scoped work, record acceptance result, unresolved gates, buyer next action, and recommended expansion package.
- Fields: Delivered artifacts, Acceptance result, Open gates, Buyer next action, Recommended package
- Release: Buyer-facing after delivery and claim review.
- Does not create implementation approval, contract commitment, customer permission, revenue guarantee, or profit guarantee.
Retainer and Internal Research Backlog
Route recurring review loops, innovation work, and future research assignments without public commitments.
- Fields: Research topic, Owner, Risk, Disclosure status, Approval gate
- Release: Internal-only unless founder and qualified reviewers approve disclosure.
- Does not create public quantum capability, production roadmap commitment, or autonomous remediation promise.
Package bindings
Packages stay profitable because handoffs, templates, and boundaries are attached up front.
Assessment Package
Synthetic Pilot Evaluation or Interoperability Readiness Sprint
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, workflow-and-system-boundary-map, synthetic-fixture-and-evidence-plan, standards-and-record-safety-crosswalk, trustos-claim-and-authority-review, delivery-retro-expansion-recommendation
- No live clinical care; No PHI; No legal, accounting, tax, security, or regulatory approval; No guaranteed savings
Readiness Sprint Package
Synthetic Pilot Evaluation or Enterprise Proof and Deal Room Activation
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, workflow-and-system-boundary-map, synthetic-fixture-and-evidence-plan, standards-and-record-safety-crosswalk, delivery-retro-expansion-recommendation
- No certified compliance claim; No production connector approval; No regional approval claim; No implementation work without SOW
Synthetic Pilot Package
Protected Enterprise Pilot or Enterprise Operating Layer License
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, synthetic-fixture-and-evidence-plan, trustos-claim-and-authority-review, buyer-proof-packet-release, delivery-retro-expansion-recommendation
- Synthetic only; No autonomous clinical action; No customer-value claim without permission; No protected evidence release without AAL2 gate
Enterprise Activation Package
Multi-year enterprise operating license or strategic platform partnership
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, workflow-and-system-boundary-map, trustos-claim-and-authority-review, buyer-proof-packet-release, delivery-retro-expansion-recommendation
- No contract approval without executive and counsel review; No production activation without customer authority; No PHI without approved BAA/security controls; No margin or revenue guarantee
Continuous Review Retainer
Enterprise operating cadence, renewal health packet, or internal research roadmap
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, trustos-claim-and-authority-review, buyer-proof-packet-release, delivery-retro-expansion-recommendation
- No managed SOC/MDR claim; No error-free AI claim; No autonomous production change; Quantum and frontier research stay internal until approved
Live Service Activation Matrix
Every service has a safe deployment posture before SCRIMED discusses go-live, revenue, or support.
Workflow Intelligence Assessment Delivery
Keep this offer in public demo and qualification mode until scope, owner, review, and acceptance evidence are stronger.
- Sales readiness: 82
- Delivery readiness: 78
- Revenue readiness: 80
- Support readiness: 74
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /product, /growth-engine, /operational-efficiency
- Production authority: false
- Human review required: true
Health Records Safety Assessment Delivery
Package a no-PHI delivery kickoff with owner map, work-order template, acceptance criteria, and claims-safe follow-up.
- Sales readiness: 90
- Delivery readiness: 92
- Revenue readiness: 86
- Support readiness: 84
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /health-records, /interoperability, /clinical-authority-readiness, /boundary-resolution
- Production authority: false
- Human review required: true
Interoperability Readiness Sprint Delivery
Package a no-PHI delivery kickoff with owner map, work-order template, acceptance criteria, and claims-safe follow-up.
- Sales readiness: 90
- Delivery readiness: 92
- Revenue readiness: 86
- Support readiness: 84
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /interoperability, /interoperability/evaluations, /integrations/fixture-validation, /platform-power
- Production authority: false
- Human review required: true
TrustOS AI Governance Audit Delivery
Keep this offer in public demo and qualification mode until scope, owner, review, and acceptance evidence are stronger.
- Sales readiness: 82
- Delivery readiness: 78
- Revenue readiness: 80
- Support readiness: 74
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /trust-os, /qa-claim-guard, /approvals-readiness, /global-certification-readiness
- Production authority: false
- Human review required: true
Synthetic Pilot Evaluation Delivery
Prepare protected-pilot workspace plan and AAL2 release chain before any customer-specific evidence or execution.
- Sales readiness: 86
- Delivery readiness: 84
- Revenue readiness: 88
- Support readiness: 80
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /pilots, /evaluation, /qa-evidence, /qa-buyer-proof-release, /pilot-workspace/access
- Production authority: false
- Human review required: true
Enterprise Proof and Deal Room Delivery
Prepare protected-pilot workspace plan and AAL2 release chain before any customer-specific evidence or execution.
- Sales readiness: 86
- Delivery readiness: 84
- Revenue readiness: 88
- Support readiness: 80
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /pilot-deal-room, /buyer-release-control-run, /pilot-workspace/access, /enterprise-business-ops
- Production authority: false
- Human review required: true
Continuous Review and Innovation Retainer Delivery
Package a no-PHI delivery kickoff with owner map, work-order template, acceptance criteria, and claims-safe follow-up.
- Sales readiness: 90
- Delivery readiness: 92
- Revenue readiness: 86
- Support readiness: 84
- Required before live: Named buyer sponsor, workflow owner, delivery owner, and review owner; No-PHI intake and scope matrix accepted; Acceptance criteria and proof routes recorded; Claim Guard review for buyer-facing language; Enterprise Business Ops review for pricing, contract, margin, billing, tax, and accounting language; Protected workspace, AAL2 release chain, and customer permission before buyer-specific protected evidence
- Safe launch motion: Launch as no-PHI service delivery, buyer demo, readiness assessment, or protected-pilot candidate only.
- Revenue motion: Use fixed scope, capped deliverables, paid readiness/pilot packaging, and separate change-order paths for expansion.
- Support motion: Offer launch-window coordination and review cadence; do not promise contractual SLA, 24/7 production support, or managed-service coverage.
- Blocked before go-live: PHI processing authority; Production connector approval; EHR writeback, payer submission, patient outreach, diagnosis, treatment, prescribing, or live clinical workflow; Customer go-live approval; Contractual SLA, uptime guarantee, managed-service commitment, security certification, compliance certification, clinical validation, revenue guarantee, or profit guarantee
- Proof routes: /service-delivery, /offerings, /continuous-review-audit, /service-reliability, /operational-efficiency, /qa-evidence
- Production authority: false
- Human review required: true